Drugs / ADHEXIL
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00544310 | Jan → Oct 2008 | ovarian disorder | OMRIX Biopharmaceuticals | Unknown | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00865488 | May 2009 → Feb 2010 | endometriosis, ovarian cyst | OMRIX Biopharmaceuticals | Suspended | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ADHEXIL | “Adhexil™ contains the components that form the anti-adhesive barrier, BAC and Thrombin.” NCT00544310 ↗ |